Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.
Methods Mol Biol, 2024;2833:23-33.
Daniel C[1], Willcocks S[1, 2], Bhakta S[3]
Affiliations
PMID: 38949697DOI: 10.1007/978-1-0716-3981-8_3
Abstract
Mycobacterium tuberculosis is the main causative agent of tuberculosis (TB)-an ancient yet widespread global infectious disease to which 1.6 million people lost their lives in 2021. Antimicrobial resistance (AMR) has been an ongoing crisis for decades; 4.95 million deaths were associated with antibiotic resistance in 2019. While AMR is a multi-faceted problem, drug discovery is an urgent part of the solution and is at the forefront of modern research.The landscape of drug discovery for TB has undoubtedly been transformed by the development of high-throughput gene-silencing techniques that enable interrogation of every gene in the genome, and their relative contribution to fitness, virulence, and AMR. A recent advance in this area is CRISPR interference (CRISPRi). The application of this technique to antimicrobial susceptibility testing (AST) is the subject of ongoing research in basic science.CRISPRi technology can be used in conjunction with the high-throughput SPOT-culture growth inhibition assay (HT-SPOTi) to rapidly evaluate and assess gene essentiality including non-essential, conditionally essential (by using appropriate culture conditions), and essential genes. In addition, the HT-SPOTi method can develop drug susceptibility and drug resistance profiles.This technology is further useful for drug discovery groups who have designed target-based inhibitors rationally and wish to validate the primary mechanisms of their novel compounds' antibiotic action against the proposed target.
Keywords: Antimicrobial susceptibility testing; CRISPRi; Gene essentiality; Mycobacteria; Target validation
MeSH terms
Microbial Sensitivity Tests; Mycobacterium tuberculosis; Drug Discovery; Gene Silencing; Humans; CRISPR-Cas Systems; Antitubercular Agents; Anti-Bacterial Agents; High-Throughput Screening Assays; Drug Resistance, Bacterial; Tuberculosis
More resources
EndNote: Download